论文部分内容阅读
目的 评价醒脑静治疗椎 -基底动脉供血不足 (VBI)的临床疗效及对椎动脉血流的影响。方法 将70例VBI患者随机分成治疗组和对照组 ,观察疗效 ,治疗前后彩色普勒超声检测椎动脉血流参数。结果 治疗组显效率和有效率明显高于对照组 (P <0 .0 5 ,P <0 .0 1) ;治疗组起效时间及最大效应时间均较对照组明显缩短 (P<0 .0 0 5 ,P <0 .0 0 1) ;治疗组中治后各参数均较治疗前明显改善 (P <0 .0 5 ,P <0 .0 0 1) ,且两组治疗后相比治疗组各参数均明显较对照组改善 (P <0 .0 0 5 ,P <0 .0 0 1)。结论 醒脑静具有扩张椎动脉和解痉作用 ,从而改善血供 ,是治疗VBI安全、有效的药物。
Objective To evaluate the clinical efficacy of xingnaojing in treating vertebrobasilar insufficiency (VBI) and its effect on vertebral artery blood flow. Methods Seventy patients with VBI were randomly divided into treatment group and control group. The therapeutic effect was observed. The blood flow parameters of vertebral artery were detected by color Doppler sonography before and after treatment. Results The effective rate and effective rate of the treatment group were significantly higher than those of the control group (P <0.05, P <0.01); the onset time and the maximum effect time of the treatment group were significantly shorter than those of the control group (P <0. 0 (P0.05, P0.01). After treatment, the parameters in the treatment group were significantly improved after treatment (P0.05, P0.01) Group parameters were significantly improved compared with the control group (P <0.05, P <0.001). Conclusion Xingnaojing has the expansion of vertebral artery and antispasmodic effect, so as to improve blood supply, is a safe and effective treatment of VBI drugs.